文献速递青光眼

局部前列腺素类似物使用与自然流产风险的关联

Association of Topical Prostaglandin Analogue Use With Risk of Spontaneous Abortion.
PubMed 文献 · JAMA Ophthalmol · 2022-01-01

该研究基于美国2006至2020年健康索赔数据库,比较使用局部前列腺素类似物(PGA)的孕妇与未使用PGA的随机样本的自然流产比例。结果显示PGA队列中12人(4.6%)在妊娠编码后90天内有自然流产编码且存在PGA重叠处方,对照组801次妊娠中56次自然流产(7%),风险增加2.4%(95%CI,-0.7%至5.4%;P=0.17)。作者认为该病例系列研究提示PGA使用与自然流产风险无关联。

要点

  • PGA队列3881人中261人妊娠,其中26人有自然流产编码,12人(4.6%)在妊娠编码后90天内自然流产且有PGA重叠处方。
  • 对照组801次妊娠中56次自然流产(7%),风险增加2.4%(95%CI,-0.7%至5.4%;P=0.17)。
  • 作者认为该病例系列研究结果提示PGA使用与自然流产风险无关联。

核心结论

  • 该病例系列研究结果提示局部前列腺素类似物使用与自然流产风险无关联。
  • 鉴于研究设计性质和潜在未测量混杂因素,这些结果可在未来流行病学研究中进一步探讨,以更好控制潜在混杂变量并通过围产期数据库更准确确定自然流产。

研究设计与样本

  • 数据源为美国2006至2020年健康索赔数据库PharMetrics Plus(IQVIA)。
  • 在15至45岁妊娠并在此期间使用局部PGA药物的患者中量化自然流产百分比,并与数据库中未使用PGA的随机样本比较。
  • 共识别3881名被处方PGA的育龄期人员和3881名未使用PGA的对照参与者。
  • 自然流产诊断通过操作编码或国际疾病分类第九版和第十版编码确定。

主要发现

  • PGA队列3881名患者中261人妊娠,26人有自然流产编码。
  • 26人中12人(4.6%)在妊娠编码后90天内有自然流产编码且存在PGA重叠处方。
  • 12人中5人(41.7%)属于40至45岁年龄组。
  • 对照组有801次妊娠,其中56次导致自然流产(7%),风险增加2.4%(95%CI,-0.7%至5.4%;P=0.17)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 鉴于研究设计性质和潜在未测量混杂因素,这些结果可在未来流行病学研究中进一步探讨,以更好控制潜在混杂变量并通过围产期数据库更准确确定自然流产。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Recent case reports suggest use of topical prostaglandin analogues (PGAs) might increase the risk of spontaneous abortions in pregnant people who take these drugs for intraocular pressure control. However, because these reports are derived mainly from voluntary adverse drug reaction databases, they might be prone to reporting bias. OBJECTIVE: To examine the risk of spontaneous abortions among pregnant people who take topical PGAs. DESIGN, SETTING, AND PARTICIPANTS: The PharMetrics Plus database (IQVIA) for health claims in the United States from 2006 to 2020 was used as the data source. The percentage of spontaneous abortions was quantified among patients aged 15 to 45 years who were pregnant and took a topical PGA medication during this period compared with a random sample of people in the database not taking a PGA agent. MAIN OUTCOMES AND MEASURES: Diagnosis of a spontaneous abortion was ascertained through procedure codes or codes from the International Classification of Diseases, Ninth Revision, and International Statistical Classification of Diseases and Related Health Problems, Tenth Revision. RESULTS: A total of 3881 people of reproductive age who were prescribed PGAs and 3881 control participants not taking PGAs were identified. Among the 3881 patients in the PGA cohort, 261 were pregnant and 26 had a spontaneous abortion code. Among the 26 individuals, 12 (4.6%) had a spontaneous abortion code within 90 days of the pregnancy code and had an overlapping prescription for a PGA. Among the 12 individuals, 5 (41.7%) were in the age category 40 to 45 years. In the control group, there were 801 pregnancies, 56 of which led to spontaneous abortions (7%), resulting in an increased risk of 2.4% (95% CI, -0.7% to 5.4%; P = .17). CONCLUSION AND RELEVANCE: The results of this case-series study suggest no association between use of PGAs and risk of spontaneous abortions. Given the nature of this study design and potential for unmeasured confounding factors, these results could be explored further in future epidemiologic studies that can better control for potential confounding variables and more accurately ascertain spontaneous abortions through perinatal databases.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Etminan M, Richter L, Sodhi M, et al. Association of Topical Prostaglandin Analogue Use With Risk of Spontaneous Abortion. JAMA Ophthalmol. 2022. PMID: 35482340. doi:10.1001/jamaophthalmol.2022.0628

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。